16243802

Source:http://linkedlifedata.com/resource/pubmed/id/16243802

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034804, umls-concept:C0035363, umls-concept:C0039286, umls-concept:C0087111, umls-concept:C0278493, umls-concept:C0681842, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	20
pubmed:dateCreated	2005-10-24
pubmed:abstractText	To evaluate the predictive value of the disintegrin and metalloproteinases, ADAM-9, ADAM-10, ADAM-11, and ADAM-12, and of the matrix metalloproteinases, MMP-2 and MMP-9, in patients with recurrent breast cancer treated with tamoxifen.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/ADAM Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1078-0432
pubmed:author	pubmed-author:ArnoldMirandaM, pubmed-author:FoekensJohn AJA, pubmed-author:GarciaRoberto RodriguezRR, pubmed-author:GoedheerAnneke J WAJ, pubmed-author:KlijnJan G MJG, pubmed-author:Meijer-van GelderMarion EME, pubmed-author:PortengenHenkH, pubmed-author:SieuwertsAnieta MAM, pubmed-author:TimmermansMiekeM, pubmed-author:TrapmanAnita M A CAM
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	7311-21
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16243802-ADAM Proteins, pubmed-meshheading:16243802-Adult, pubmed-meshheading:16243802-Aged, pubmed-meshheading:16243802-Aged, 80 and over, pubmed-meshheading:16243802-Antineoplastic Agents, Hormonal, pubmed-meshheading:16243802-Breast Neoplasms, pubmed-meshheading:16243802-Female, pubmed-meshheading:16243802-Gene Expression Profiling, pubmed-meshheading:16243802-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16243802-Humans, pubmed-meshheading:16243802-Immunohistochemistry, pubmed-meshheading:16243802-Matrix Metalloproteinase 2, pubmed-meshheading:16243802-Matrix Metalloproteinase 9, pubmed-meshheading:16243802-Middle Aged, pubmed-meshheading:16243802-Multivariate Analysis, pubmed-meshheading:16243802-Neoplasm Recurrence, Local, pubmed-meshheading:16243802-Predictive Value of Tests, pubmed-meshheading:16243802-Prognosis, pubmed-meshheading:16243802-RNA, Messenger, pubmed-meshheading:16243802-Receptors, Estrogen, pubmed-meshheading:16243802-Receptors, Progesterone, pubmed-meshheading:16243802-Retrospective Studies, pubmed-meshheading:16243802-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16243802-Survival Analysis, pubmed-meshheading:16243802-Tamoxifen
pubmed:year	2005
pubmed:articleTitle	How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
pubmed:affiliation	Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands. a.sieuwerts@erasmusmc.nl
pubmed:publicationType	Journal Article